跳至主要内容
临床试验/IRCT201311014105N16
IRCT201311014105N16已完成未知

Comparison the effect of coenzyme Q10 and placebo on clinical sings, inflammatory factors, matrix metalloproteinases and oxidative status in rheumatoid arthritis patients

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria:
  • Disease diagnosis based on ACR criteria by expert; Fixed type and dose of drugs one month before intervention to the end of the study; Under treatment with DMARDs (Hydroxychloroquine, Prednisone, Methotrexate, Sulfasalazine, and ...); Patients with moderate and severe disease; Catching RA disease at least six months ago; Age between 18 to 65 years; Consent to participate in the study
  • Exclusion criteria:
  • Simultaneously participate in trials of other investigators; Pregnancy or the decision to become pregnant during the study period; Breastfeeding; Taking contraceptive drugs; Consumption of antioxidant supplements (A, C, E); Consumption of omega-3 fatty acids; Having liver, kidney, thyroid, diabetes, or infectious disease; Taking anticoagulants such as warfarin; Smoking or repeated exposure to smoking; Drug addiction; Not wanting to continue; Less than 70% adherence

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验